|
EPS15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.00020000000234E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.636500E-04 |
| Normal-vs-Stage2 |
1.684250E-03 |
| Normal-vs-Stage3 |
1.640730E-04 |
| Normal-vs-Stage4 |
4.25720000000185E-05 |
| Stage1-vs-Stage2 |
4.408000E-01 |
| Stage1-vs-Stage3 |
1.095780E-01 |
| Stage1-vs-Stage4 |
7.202200E-02 |
| Stage2-vs-Stage3 |
7.062600E-01 |
| Stage2-vs-Stage4 |
4.359200E-01 |
| Stage3-vs-Stage4 |
6.661600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.26310000000152E-05 |
| Normal-vs-AfricanAmerican |
1.980840E-01 |
| Normal-vs-Asian |
3.157700E-03 |
| Caucasian-vs-AfricanAmerican |
1.360230E-01 |
| Caucasian-vs-Asian |
7.331800E-01 |
| AfricanAmerican-vs-Asian |
2.638200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.163160E-04 |
| Normal-vs-Female |
1.992740E-04 |
| Male-vs-Female |
6.037000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.502200E-03 |
| Normal-vs-Age(41-60Yrs) |
5.9673999999954E-05 |
| Normal-vs-Age(61-80Yrs) |
9.59649999999757E-05 |
| Normal-vs-Age(81-100Yrs) |
7.318700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.311900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.367550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.445550E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.710800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.694200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.554000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.282400E-01 |
| Classical-VS-Follicular |
7.797600E-01 |
| Classical-VS-Other |
5.854400E-01 |
| Classical-VS-Normal |
5.170400E-04 |
| Tall-VS-Follicular |
3.476600E-01 |
| Tall-VS-Other |
9.710200E-01 |
| Tall-VS-Normal |
2.444000E-03 |
| Follicular-VS-Other |
5.838800E-01 |
| Follicular-VS-Normal |
1.235520E-02 |
| Other-VS-Normal |
6.157800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.589570E-04 |
| Normal-vs-N1 |
1.67557999999346E-05 |
| N0-vs-N1 |
1.387760E-01 |
|
|
